Loading Events

« All Events

Endocrinologic and Metabolic Drugs Advisory Committee

January 17, 2019

The committee will discuss new drug application 210934 for sotagliflozin oral tablet, sponsored by Sanofi-Aventis U.S., LLC, for the proposed indication: Adjunct to insulin therapy to improve glycemic control in adults with type 1 diabetes mellitus.

Details

Date:
January 17, 2019
Event Category: